Hippocratic AI is scaling up its leadership team with several high-profile executive hires, each tasked with expanding the company’s reach across new market sectors and global territories. This move comes on the heels of its successful $141 million Series B funding round and the strong reception of its Polaris 3.0 AI agent platform, which has already demonstrated impressive clinical accuracy and patient satisfaction metrics. The company’s newly appointed leaders—ranging from specialists in pharma and life sciences to those focused on payors, providers, ambulatory care, government, and emerging international markets—bring deep industry experience and are strategically positioned to drive Hippocratic AI’s mission of advancing healthcare accessibility through generative AI technologies.
Each new executive brings a focused mandate. Chris Fang will spearhead international and pharma sector growth; Hollie Vugrinovich will expand partnerships with providers; Jonathan Gainor and Chitra Laxmanan will enhance payor engagement and scalability; Mitch Mitchell will coordinate government sector initiatives; Brij Aswani will lead ambulatory care expansion; and Eric Seastedt will develop global partnerships in emerging markets. Their combined expertise underscores Hippocratic AI’s intention to integrate its safety-focused AI agents into healthcare systems at scale—boosting operational efficiency, improving patient outcomes, and addressing workforce shortages across various care settings and regions worldwide.